查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球罕見病治療市場規模、研究與預測、按治療領域、給藥途徑、藥物類型、分銷渠道、地區分析
市場調查報告書
商品編碼
1251572

2022-2029 年全球罕見病治療市場規模、研究與預測、按治療領域、給藥途徑、藥物類型、分銷渠道、地區分析

Global Rare Diseases Treatment Market Size study & Forecast, by Therapeutic Area by Route of Administration, by Drug Type, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球罕見病治療市場價值 1196 億美元，預計在 2022-2029 年預測期內將以超過 12.8% 的強勁增長率增長。

罕見病是指只影響一小部分人的疾病。 ICD-11 被世界衛生組織編碼為 ICD-11，包括大約 5500 種罕見病。 罕見病，也稱為孤兒病，沒有足夠的市場規模來籌集治療開發的資金和資源，經濟條件有利於政府開發和商業化此類治療。它指的是禁止給予的狀態 根據美國食品和藥物管理局 (FDA) 的說法，孤兒病是一種影響該國不到 2,000 人的疾病。 新藥批准和上市的增加、罕見病患病率的增加、政府對治療罕見病的支持和承諾、該領域研究和開發的增加以及有利的政府政策是促進市場增長的因素。它是

根據美國國立衛生研究院的數據，十分之一的美國人（約 3000 萬人）患有罕見病，美國約有 7000 種已確診的罕見病。 2022 年 1 月，Amgen 宣佈在日本批准 Lumaclas 製劑作為孤兒癌症治療藥物，2021 年 10 月，Cembrix 製劑在慢性期（CP）-CML 患者中上市。食品和藥物管理局批准作為下一個-線療法。 新孤兒藥的批准和上市增加以及罕見病患病率的增加是推動市場增長的主要因素。 此外，增加政府舉措和提高對罕見疾病的認識是在預測期內創造重要市場機會的因素。 然而，罕見病治療的高成本阻礙了整個 2022-2029 年預測期內的市場增長。

在罕見病治療的全球市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於北美在罕見疾病領域的主導地位、產品的易獲得性、新產品的批准以及政府支持和投資的增加，北美在收入方面佔據了市場主導地位。 由於政府舉措的增加、罕見疾病患病率上升、主要參與者的區域擴張以及政府的積極參與等因素，預計亞太地區在預測期內將以最高的複合年增長率增長。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年全球和細分市場估計和預測
    • 2019-2029 年按地區劃分的罕見病治療市場
    • 罕見病療法市場，按治療領域劃分，2019-2029 年
    • 罕見病治療市場，按藥物類型劃分，2019-2029 年
    • 罕見病治療市場，按給藥途徑，2019-2029 年
    • 罕見病治療市場，按分銷渠道，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章全球罕見病治療市場的定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第 3 章全球罕見病治療的市場動態

  • 罕見病治療市場影響分析（2019-2029）
    • 市場驅動力
      • 孤兒藥的新批准和上市將會增加
      • 罕見病增加
    • 市場挑戰
      • 罕見病的昂貴治療
    • 市場機會
      • 激活政府舉措
      • 提高對罕見病的認識

第四章全球罕見病治療市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的建議和結論
  • 主要投資機會
  • 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章。全球罕見病治療市場：按治療領域分類

  • 市場概況
  • 全球罕見病治療市場：按治療領域、性能潛力分析
  • 全球罕見病治療市場：2019-2029 年各治療領域的估計和預測
  • 罕見病治療市場，按細分市場分析
    • 癌症
    • 神經系統疾病
    • 心血管疾病
    • 肌肉骨骼疾病
    • 血液病
    • 感染
    • 代謝綜合徵
    • 內分泌疾病
    • 其他

第 7 章。全球罕見病治療市場：按藥物類型分類

  • 市場概況
  • 全球罕見病治療市場：按藥物類型進行性能潛力分析
  • 全球罕見病治療市場：2019-2029 年按藥物類型估算和預測
  • 罕見病治療市場，按細分市場分析
    • 生物製劑
    • 生物仿製藥
    • 低分子化合物

第 8 章。全球罕見病治療市場：按給藥途徑

  • 市場概況
  • 罕見病療法的全球市場：按給藥途徑進行的性能潛力分析
  • 罕見病療法的全球市場：2019-2029 年按給藥途徑的估計和預測
  • 罕見病治療市場，按細分市場分析
    • 口語
    • 可注射
    • 其他

第 9 章。全球罕見病治療市場：按分銷渠道

  • 市場概況
  • 罕見病療法的全球市場：按分銷渠道進行的性能潛力分析
  • 全球罕見病治療市場：2019-2029 年按分銷渠道估算和預測
  • 罕見病治療市場，按細分市場分析
    • 醫院藥房
    • 專業藥房
    • 在線藥店

第 10 章。全球罕見病治療市場：區域分析

  • 罕見病治療藥物市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年各治療領域的估計和預測
      • 2019-2029 年按藥物類型估算和預測
      • 按給藥途徑估算和預測，2019-2029 年
      • 2019-2029 年各分銷渠道的估計和預測
    • 加拿大
  • 歐洲罕見病治療市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區罕見病治療藥物市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲罕見病療法市場概況
    • 巴西
    • 墨西哥
  • 世界其他地方

第 11 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • F. Hoffmann-La Roche Ltd.
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概述
      • 近期趨勢
    • Pfizer, Inc
    • PTC Therapeutics
    • AstraZeneca
    • Novartis AG
    • Novo Nordisk Pharmatech A/S
    • Takeda Pharmaceutical Company Limited
    • Bayer AG
    • Merck & Co., Inc.
    • Bristol Myers Squibb Company

第 12 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Rare Diseases Treatment Market is valued at approximately USD 119.6 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 12.8% over the forecast period 2022-2029. Rare Diseases are diseases that affect a small percentage of people. It is coded as ICD-11 by the world health organization, ICD-11 consists of around 5500 rare diseases. Rare disease can also be termed as an orphan disease, a condition that lacks a market size large enough to attract funding and resources for the development of remedies, barring the government from giving favorable economic terms for developing and commercializing such treatments. According to the US Food and Drug Administration, a rare disease is one that affects less than two lakh persons in the country. Increasing approval and launch of new orphan drugs, increasing prevalence of rare diseases, government support and initiatives for the treatment of rare diseases, increasing research and development in the sector, and favorable government policies are the factors contributing to the growth of the market.

According to the National Institutes of Health, One in ten Americans (about 30 million people) have a rare condition, and there are approximately 7,000 identified rare diseases in the US. Additionally, In January 2022, Amgen announced the approval of LUMAKRAS® drug in Japan for the treatment of rare cancer, and in October 2021, Scemblix drug was approved by the Food and Drug Administration for patients with chronic-phase (CP)-CML as a third line of treatment. Increasing approval and launch of new orphan drugs and increasing prevalence of rare diseases are the major factors driving the growth of the market. Furthermore, Increasing initiatives by the government and increasing awareness of rare diseases are the factors creating major market opportunities in the forecast period. However, the high cost of Rare Diseases Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Rare Diseases Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of rare diseases, easy accessibility to products, new product approval, and increasing government support and investment in the region. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising government initiatives, increasing prevalence of orphan diseases, geographic expansion of key players, and active participation of government.

Major market players included in this report are:

  • F. Hoffmann-La Roche Ltd.
  • Pfizer, Inc
  • PTC Therapeutics
  • AstraZeneca
  • Novartis AG
  • Novo Nordisk Pharmatech A/S
  • Takeda Pharmaceutical Company Limited
  • Bayer AG
  • Merck & Co., Inc.
  • Bristol Myers Squibb Company

Recent Developments in the Market:

  • In July 2021, AstraZeneca acquired Alexion Pharmaceuticals, Inc. to enjoy a stronger scientific foothold in immunology and to continue to lead the way in the research and development of drugs for people with rare diseases through Alexion's cutting-edge complement-biology platform and a strong pipeline.
  • In November 2022, The FDA received a new Biologics License Application (BLA) for PRX-102 (pegunigalsidasealfa) from ProtalixBiotherapeutics Inc. and Chiesi Global Rare Diseases for the treatment of adult Fabry disease patients.

Global Rare Diseases Treatment Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Therapeutic Area, Route of Administration, Drug Type, Distribution Channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Therapeutic Area offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutic Area:

  • Cancer
  • Neurological Conditions
  • Cardiovascular Conditions
  • Musculoskeletal Conditions
  • Hematologic Disorders
  • Infectious Diseases
  • Metabolic disorders
  • Endocrine disorders
  • Others

By Drug Type:

  • Biologics
  • Biosimilar
  • Small Molecule

By Route of Administration:

  • Oral
  • Injectable
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Specialty Pharmacy
  • Online Pharmacy

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Rare Diseases Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Rare Diseases Treatment Market, by Therapeutic Area, 2019-2029 (USD Billion)
    • 1.2.3. Rare Diseases Treatment Market, by Drug Type, 2019-2029 (USD Billion)
    • 1.2.4. Rare Diseases Treatment Market, by Route of Administration, 2019-2029 (USD Billion)
    • 1.2.5. Rare Diseases Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Rare Diseases Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Rare Diseases Treatment Market Dynamics

  • 3.1. Rare Diseases Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing approval and launch of new orphan drugs
      • 3.1.1.2. Increasing prevalence of rare diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Rare Diseases Treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing initiatives by the government
      • 3.1.3.2. Increasing awareness of rare diseases

Chapter 4. Global Rare Diseases Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Rare Diseases Treatment Market, by Therapeutic Area

  • 6.1. Market Snapshot
  • 6.2. Global Rare Diseases Treatment Market by Therapeutic Area, Performance - Potential Analysis
  • 6.3. Global Rare Diseases Treatment Market Estimates & Forecasts by Therapeutic Area 2019-2029 (USD Billion)
  • 6.4. Rare Diseases Treatment Market, Sub Segment Analysis
    • 6.4.1. Cancer
    • 6.4.2. Neurological Conditions
    • 6.4.3. Cardiovascular Conditions
    • 6.4.4. Musculoskeletal Conditions
    • 6.4.5. Hematologic Disorders
    • 6.4.6. Infectious Diseases
    • 6.4.7. Metabolic disorders
    • 6.4.8. Endocrine disorders
    • 6.4.9. Others

Chapter 7. Global Rare Diseases Treatment Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global Rare Diseases Treatment Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global Rare Diseases Treatment Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
  • 7.4. Rare Diseases Treatment Market, Sub Segment Analysis
    • 7.4.1. Biologics
    • 7.4.2. Biosimilar
    • 7.4.3. Small Molecule

Chapter 8. Global Rare Diseases Treatment Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Rare Diseases Treatment Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Rare Diseases Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
  • 8.4. Rare Diseases Treatment Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Injectable
    • 8.4.3. Others

Chapter 9. Global Rare Diseases Treatment Market, by Distribution Channel

  • 9.1. Market Snapshot
  • 9.2. Global Rare Diseases Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 9.3. Global Rare Diseases Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 9.4. Rare Diseases Treatment Market, Sub Segment Analysis
    • 9.4.1. Hospital Pharmacy
    • 9.4.2. Specialty Pharmacy
    • 9.4.3. Online Pharmacy

Chapter 10. Global Rare Diseases Treatment Market, Regional Analysis

  • 10.1. Rare Diseases Treatment Market, Regional Market Snapshot
  • 10.2. North America Rare Diseases Treatment Market
    • 10.2.1. U.S. Rare Diseases Treatment Market
      • 10.2.1.1. Therapeutic Area breakdown estimates & forecasts, 2019-2029
      • 10.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
      • 10.2.1.3. Route of Administration breakdown estimates & forecasts, 2019-2029
      • 10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 10.2.2. Canada Rare Diseases Treatment Market
  • 10.3. Europe Rare Diseases Treatment Market Snapshot
    • 10.3.1. U.K. Rare Diseases Treatment Market
    • 10.3.2. Germany Rare Diseases Treatment Market
    • 10.3.3. France Rare Diseases Treatment Market
    • 10.3.4. Spain Rare Diseases Treatment Market
    • 10.3.5. Italy Rare Diseases Treatment Market
    • 10.3.6. Rest of Europe Rare Diseases Treatment Market
  • 10.4. Asia-Pacific Rare Diseases Treatment Market Snapshot
    • 10.4.1. China Rare Diseases Treatment Market
    • 10.4.2. India Rare Diseases Treatment Market
    • 10.4.3. Japan Rare Diseases Treatment Market
    • 10.4.4. Australia Rare Diseases Treatment Market
    • 10.4.5. South Korea Rare Diseases Treatment Market
    • 10.4.6. Rest of Asia Pacific Rare Diseases Treatment Market
  • 10.5. Latin America Rare Diseases Treatment Market Snapshot
    • 10.5.1. Brazil Rare Diseases Treatment Market
    • 10.5.2. Mexico Rare Diseases Treatment Market
  • 10.6. Rest of The World Rare Diseases Treatment Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Pfizer, Inc
    • 11.2.3. PTC Therapeutics
    • 11.2.4. AstraZeneca
    • 11.2.5. Novartis AG
    • 11.2.6. Novo Nordisk Pharmatech A/S
    • 11.2.7. Takeda Pharmaceutical Company Limited
    • 11.2.8. Bayer AG
    • 11.2.9. Merck & Co., Inc.
    • 11.2.10. Bristol Myers Squibb Company

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Rare Diseases Treatment Market, report scope
  • TABLE 2. Global Rare Diseases Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Rare Diseases Treatment Market estimates & forecasts by Therapeutic Area 2019-2029 (USD Billion)
  • TABLE 4. Global Rare Diseases Treatment Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 5. Global Rare Diseases Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
  • TABLE 6. Global Rare Diseases Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 7. Global Rare Diseases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Rare Diseases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Rare Diseases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Rare Diseases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Rare Diseases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Rare Diseases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Rare Diseases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Rare Diseases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Rare Diseases Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. Global Rare Diseases Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. U.S. Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. U.S. Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. Canada Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. Canada Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. UK Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. UK Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. Germany Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. Germany Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. France Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. France Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Italy Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Italy Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. Spain Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. Spain Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. RoE Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. RoE Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. China Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. China Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. India Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. India Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. Japan Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. Japan Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. South Korea Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. South Korea Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. Australia Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. Australia Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. RoAPAC Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Brazil Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Brazil Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. Mexico Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. Mexico Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. RoLA Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. RoLA Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Rare Diseases Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 69. Row Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. Row Rare Diseases Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 71. List of secondary sources, used in the study of global Rare Diseases Treatment Market
  • TABLE 72. List of primary sources, used in the study of global Rare Diseases Treatment Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Rare Diseases Treatment Market, research methodology
  • FIG 2. Global Rare Diseases Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Rare Diseases Treatment Market, key trends 2021
  • FIG 5. Global Rare Diseases Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Rare Diseases Treatment Market, porters 5 force model
  • FIG 7. Global Rare Diseases Treatment Market, pest analysis
  • FIG 8. Global Rare Diseases Treatment Market, value chain analysis
  • FIG 9. Global Rare Diseases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Rare Diseases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Rare Diseases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Rare Diseases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Rare Diseases Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Rare Diseases Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Rare Diseases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Rare Diseases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Rare Diseases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Rare Diseases Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Rare Diseases Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable